Publication | Open Access

Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study

FibrosisExtracellular Matrix TurnoverInflammatory Lung DiseaseLung InflammationIdiopathic Pulmonary FibrosisPathologyPulmonary FibrosisInmark StudyMedicinePulmonary Disease